Pharmaceutical law in transition: What is the EU Pharma Package and when does it apply?
The EU Pharma Package, also called the pharmaceutical package, is the first comprehensive overhaul of the European legal regulations for medicinal products since 2004 and is intended to fundamentally renew the legal framework for medicinal products for the first time in more than 20 years. The changes are intended to adapt the regulations on medicinal products to today’s healthcare supply needs. The primary focus here is on ensuring supply security for patients. At the same time, competition and innovation are to be strengthened. Targeted incentives are intended to promote investments in new antimicrobial agents, in medicines for rare diseases and in paediatric medicines, where gaps have frequently existed to date for economic reasons.
The key question for your planning is: From when do the new regulations apply? In short: The package has been politically agreed and adopted by the Council of the EU. Approval by the European Parliament and publication in the Official Journal are still pending, and the package will not become effective before then. The new regulation is expected to apply 24 months after it enters into force. Publication in the Official Journal is still expected this year. This likely means an application start between late 2028 and early 2029, unless otherwise specified in the standards.
What is the EU Pharma Package?
The package consists of two legal acts:
-
The new directive (Union code for medicinal products for human use) replaces the previous Directives 2001/83/EC and 2009/35/EC. The Member States must transpose it into national law within the period set therein before it applies there.
- The new regulation revises the centralised authorisation procedure and the European Medicines Agency (EMA). It replaces, among other things, Regulation (EC) No 726/2004 and applies directly in all Member States from its application date, without the need for a transposition act.
Why is pharmaceutical law being revised?
Where does the process stand today?
| Step | Date |
Status
|
| European Commission proposal | April 2023 | Completed |
| Political agreement between Council and Parliament | 11 December 2025 | Completed |
| Council position at first reading | 28 September 2026 |
Completed
|
| Vote in the European Parliament |
Announced for autumn 2026
|
Currently pending
|
| Publication in the Official Journal of the EU |
Expected Nov. to Dec. 2026
|
Currently pending
|
When will the EU Pharma Package become relevant?
What applies until application?
Conclusion
No. The package has been agreed upon politically and adopted by the Council. However, it has yet to be approved by Parliament and published in the Official Journal, and it will not take effect until then.
No. The package concerns human medicines. Medical devices are subject to their own legal framework, which is not affected by the package.
Immediate implementation is not required. However, it makes sense to assess which areas of your company might be affected and to keep an eye on the upcoming changes. It may be worthwhile to adapt your internal processes early on.
This could also be of interest to you:
GModG for Industrial Enterprises: Changes Compared to the GEG in Heating Systems and Building Equipment
Current Status of the Deforestation Regulation (EUDR)
EU Machinery Regulation
Your personal contact
Marie Luise Stinzendörfer
Ass. Jur.Legal Compliance Expert
m.stinzendoerfer@eticor.com
+49 171 3820 843